Antiemetic (Antihistamine H₁ Antagonist)
Pregnancy: Compatible — widely used for hyperemesis gravidarum (Cyclizine + pyridoxine is first-line). No significant teratogenicity signal.
Cyclizine
Brand names: Valoid
Adult dose
Dose: 50mg up to three times daily (oral, IV, or IM). Palliative care: 150mg/24 hours by continuous subcutaneous infusion (CSCI).
Route: Oral, IV (slow — over at least 1 minute), IM, or SC infusion
Frequency: Up to three times daily
Max: 150mg/day
Useful for vestibular nausea (motion sickness, labyrinthitis), opioid-induced nausea, raised intracranial pressure nausea. IV: give slowly — rapid IV injection causes severe tachycardia and facial flushing. Compatible with diamorphine and morphine in syringe drivers (CSCI). Incompatible with metoclopramide and haloperidol in syringe drivers.
Paediatric dose
Dose: 1 mg/kg
Route: Oral, IV (slow), or IM
Frequency: Up to three times daily
Max: 25mg per dose (children ≥6 years)
BNF for Children: 1 month–5 years: 0.5–1mg/kg (max 25mg) up to TDS; 6–11 years: 25mg up to TDS; 12–17 years: 50mg up to TDS. IV: give over at least 1 minute. Source: BNF for Children 2024.
Dose adjustments
Renal
No dose adjustment required.
Hepatic
Use with caution in hepatic impairment — increased sedation risk.
Paediatric weight-based calculator
BNF for Children: 1 month–5 years: 0.5–1mg/kg (max 25mg) up to TDS; 6–11 years: 25mg up to TDS; 12–17 years: 50mg up to TDS. IV: give over at least 1 minute. Source: BNF for Children 2024.
Clinical pearls
- Mechanism: H₁ and muscarinic antagonism — effective for vestibular, opioid-induced, and motion-related nausea. Less effective for chemotherapy-induced nausea (5-HT3 pathway dominant).
- Palliative care syringe driver: cyclizine 150mg/24h is compatible with morphine or diamorphine — but incompatible with metoclopramide, haloperidol, or ketorolac in the same syringe.
- Rapid IV injection causes severe tachycardia and flushing (histamine release) — always give IV slowly over at least 1 minute.
- Motion sickness: take 30 minutes before travel. Transdermal hyoscine (Scopoderm patch) is an alternative for prolonged journeys.
Contraindications
- Known hypersensitivity to cyclizine
- Severe heart failure (may exacerbate due to tachycardia and anticholinergic effects)
- Porphyria (relative)
Side effects
- Drowsiness (antihistamine effect)
- Dry mouth, urinary retention (anticholinergic)
- Tachycardia (especially with rapid IV injection)
- Blurred vision
- Paradoxical excitability in children (uncommon)
Interactions
- Anticholinergic drugs: additive anticholinergic effects
- CNS depressants (opioids, benzodiazepines, alcohol): enhanced sedation
- Metoclopramide / haloperidol: incompatible in syringe driver — precipitates
Monitoring
- Symptom response
- Heart rate (IV route)
- Anticholinergic burden in elderly
Reference: BNFc; BNF 90; NICE NG121 Nausea and Vomiting in Pregnancy; Palliative Care Formulary (PCF) 7th Edition. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021